Evan B. Cunningham

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 292 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

Jason Grebely, Sarah Larney, Amy Peacock et al. · Addiction · 2018 · 259 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +6

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 150 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutical Policy +13

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

Behzad Hajarizadeh, Jason Grebely, Marianne Byrne et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 98 citations · Full text

Pharmacy, Preventive Medicine, Infection Prevention +11

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

Sahar Bajis, Lisa Maher, Carla Treloar et al. · International Journal of Drug Policy · 2018 · 83 citations · Full text

Pharmacy, Preventive Medicine, Medical Ethics +8